Update on share buyback extension
Fevertree commences £30 million extension of share buyback programme until end 2026.
- Buyback extension £30 million
- Total programme maximum consideration £60 million
- Extension period until 31 December 2026
Select text to share a quote on X · sign in to keep highlights & notes in your FEVR notes
In its FY26 AGM Trading Statement published on 9 June 2026, Fever-Tree announced a £30 million extension (the "Extension") of the Company's share buyback programme announced on 2 February 2026 (the "Programme"), taking the total programme maximum consideration to £60 million. The Company today announces the commencement the Extension which is to be conducted until 31 December 2026 to buyback ordinary shares of a nominal value of 0.25 pence each (the "Shares").
Fever-Tree has amended its agreement with Investec Bank plc ("Investec") pursuant to which Investec will continue to carry out on-market purchases of Shares on its behalf and to make trading decisions independently of the Company. Save as set out herein, the Programme will otherwise continue to be subject to the same parameters set out in the Company's announcement of 2 February 2026.
Investec will purchase the Shares as principal and simultaneously be deemed to execute sales to the Company of any Shares so purchased in accordance with the terms of their engagement.
Any purchase of Shares under the Programme moving forwards will be executed in accordance with certain pre-set parameters and in accordance with the Company's existing general authority to repurchase Shares granted by its shareholders at the annual general meeting held on 9 June 2026 and any subsequent general authorities granted by the Company's shareholders, the Market Abuse Regulation (596/2014) as it forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended) and UKLR 9.6.2. The Company may repurchase up to 25% of the average daily trading volume in the Shares in the 20 trading days preceding the date on which a buy-back of Shares is carried out.
Fever-Tree is the world's leading supplier of premium carbonated mixers by retail sales value, with distribution to over 95 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.